The Discounted Cash Flow (DCF) valuation of NeuroScientific Biopharmaceuticals Ltd (NSB.AX) is 0.04 AUD. With the latest stock price at 0.05 AUD, the upside of NeuroScientific Biopharmaceuticals Ltd based on DCF is -9.6%.
Based on the latest price of 0.05 AUD and our DCF valuation, NeuroScientific Biopharmaceuticals Ltd (NSB.AX) is a sell. selling NSB.AX stocks now will result in a potential gain of 9.6%.
| Range | Selected | |
| WACC / Discount Rate | 5.6% - 9.0% | 7.3% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 0.04 - 0.06 | 0.04 |
| Upside | -17.9% - 15.7% | -9.6% |